Clinical Trials Browser

Phase 1/2 × infigratinib × Gastrointestinal × Clear all

NCT02257541 2020-03-30

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1/2 Completed

16 enrolled 14 charts

GastrointestinalSarcoma

Advanced Gastrointestinal Stromal Tumor (GIST)

NCT02575508 2016-05-20

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms